From eNewsletter 5/26/2021
DID YOU KNOW that while users tout its effectiveness for pain relief, until now there's been limited human research on the effectiveness of the cannabadiol (CBD)? A new study in Experimental and Clinical Psychopharmacology sheds light on the ability of CBD to significantly reduce pain via neurologic sensory pathways, along inducing a slight placebo effect in human subjects.
Double Sale Through Memorial Day! Starting today and running through Memorial Day on Monday, May 31st, you can purchase sale items from May and June.
New Products Pure Encapsulations debuted three new gummy supplements: Vitamin C, Vitamin D, and Zinc!
UPDATE - COVID-19 Vaccine Information We updated this document Monday May 24th.
Virus Prevention And Treatment Vaccines will minimize COVID-19 related mortality and hospitalizations, but SARS-CoV-2 is not going away, as evidenced by its ever-mutating variants. Moreover, SARS-CoV-2 is not the only virus we fight. There are influenza (flu), norovirus (stomach flu), adenovirus (common cold), and four other coronaviruses (common cold), among others.We highly recommend continuing your immune support. For more information, refer to our Prevent and Fight Viruses 2.0 Protocol.
COVID-19 Condition Monograph For those interested in conventional and integrative treatments for COVID-19 with over 250 references, this is our COVID-19 Condition Monograph.
Post-COVID Syndrome The official diagnosis for post-COVID syndrome (PCS) are symptoms that last for 12 weeks or more. If you, a family member, friend, coworker, or neighbor is suffering from PCS, diligently following our Post-COVID Syndrome Action Plan for purchase, or free to paid members here, can bring measurable improvement.
Steve and Bonnie: We've had myriad inquiries about the value of antibody testing whether you had COVID infection or not, as well as post-vaccination.
Since the beginning of the pandemic, we have recommended against antibody testing. It is comforting to know that the Food and Drug Administration (FDA) has chimed in on the issue, and have also recommended against antibody testing.
"Antibody tests can play an important role in identifying individuals who may have been exposed to the SARS-CoV-2 virus and may have developed an adaptive immune response," an FDA spokesperson added. "However, antibody tests should not be used at this time to determine immunity or protection against COVID-19 at any time, and especially after a person has received a COVID-19 vaccination."
Simply, not all antibodies are created equal and the testing for every the antibody involved in combatting COVID infection and/or immune response to vaccination are not readily available to be tested on a population-wide scale.
Erectile Dysfunction (ED)
A study from The World Journal of Men's Health has drawn a lot of attention because it is the first to demonstrate the presence of the COVID-19 virus in the penis long after the initial infection in humans. The results also suggest that widespread endothelial cell dysfunction from COVID-19 infection can contribute to ED. Future studies will evaluate how COVID-19 infection leads to ED.
There have also been anecdotal reports of this issue from males who recovered from COVID-19 infection.
Myocarditis Found in Several Fully Vaccinated Young Persons
The Centers for Disease Control is investigating several reports of mild myocarditis (heart inflammation) occurring roughly four days after the second Pfizer dose, more often in males. Israel, who is much farther along with vaccinating their young population, also reported a few cases of myocarditis in young persons.
Myocarditis has been reported in patients who contracted COVID-19 infection, so having some cases when vaccinating against the SARS-CoV-2 spike protein should not come as a total surprise.
The key takeaway here is the issue occurred after the second dose. We are only recommending healthy young people get one dose at this time.
A new study from Biorxiv states that CBD, a compound produced by the cannabis plant, inhibits SARS-CoV-2 infection. CBD and its metabolite, 7-OH-CBD, potently blocked SARS-CoV-2 replication in lung epithelial cells.
Survey: mRNA Vaccines Can Remit Post-COVID Syndrome
Covid-19 vaccines can alleviate the symptoms of "long Covid," according to a large survey of more than 800 people that suggests mRNA vaccines, in particular, are beneficial. The analysis, which is yet to be peer reviewed, was based on a survey conducted by the advocacy group LongCovidSOS involving 812 people (mostly white, female participants) with long Covid in the UK and internationally. Participants were asked to wait at least a week after their first dose to avoid their responses conflating with side-effects of the vaccine. Scores across 14 common long-Covid symptoms were compared before and after the first vaccine dose. Data showed that 56.7% of respondents experienced an overall improvement in symptoms, with 24.6% remaining unchanged and 18.7% reporting a deterioration in their symptoms.
We have alluded to the fact that COVID-19 booster shots would be floated by the drug companies, even though we do not particularly agree with this approach without more evidence, and especially without an antibody titer test. Well, we're not alone, as more than a dozen influential infectious disease and vaccine development experts said there is growing evidence that a first round of global vaccinations may offer enduring protection against the coronavirus and its most worrisome variants discovered to date.
Some of these scientists expressed concern that public expectations around COVID-19 boosters are being set by pharmaceutical executives rather than health specialists, although many agreed that preparing for such a need as a precaution was prudent. Dr. Anthony Fauci also tempered the call for booster shots as he suggests there are too many unknowns to confirm or deny their value at this time.
Common Thread Among COVID-19 Hospitalizations in 2021